• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS INC - GLASGOW DIMENSION(R) CLINICAL CHEMISTRY SYSTEM; HEMOGLOBIN A1C KIT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS INC - GLASGOW DIMENSION(R) CLINICAL CHEMISTRY SYSTEM; HEMOGLOBIN A1C KIT Back to Search Results
Catalog Number DF105A
Device Problems Calibration Problem (2890); Human-Device Interface Problem (2949)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 04/12/2014
Event Type  malfunction  
Event Description
Biased high hb1c results were obtained on qc and patient samples after calibration.Patient results were reported to the physicians.After investigation it was determined that one incorrect calibration scaler value had been entered.The scaler value was corrected and lower qc and patient results were obtained.It is unknown if patient treatment was altered or prescribed on the basis of the falsely elevated hb1c results.There was no report of adverse health consequences as a result of the falsely elevated hb1c results.
 
Manufacturer Narrative
Analysis of the instrument and instrument data indicate that the cause for the biased high hb1c results is user error.The account failed to input the correct lot specific scaler for one of the five scalers for the new lot of hb1c reagent.The falsely elevated results were caused by using the incorrect scaler and the issue was resolved by inputting the correct scaler d value, recalibrating, and verifying by qc.The hb1c method uses an additional parameter called scaler values.These values are polynomial equation factors that have been determined for hb1c in order to provide the best correlation to the hba1c reference methodology.This feature was communicated to customers with the launch of hb1c ((b)(4)) in the hb1c kit supplement.The instrument is performing within specifications.No further evaluation of the device is required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DIMENSION(R) CLINICAL CHEMISTRY SYSTEM
Type of Device
HEMOGLOBIN A1C KIT
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS INC - GLASGOW
glasgow business community
500 gbc drive
newark DE 19714
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS INC - GLASGOW
glasgow business community
500 gbc drive
newark DE 19702
Manufacturer Contact
james morgera
glasgow business community
po box 6101
newark, DE 19714-6101
3026318356
MDR Report Key3789962
MDR Text Key17385604
Report Number2517506-2014-00049
Device Sequence Number1
Product Code LCP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K102510
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Medical Technologist
Type of Report Initial
Report Date 04/21/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/05/2014
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Medical Technologist
Device Expiration Date02/10/2015
Device Catalogue NumberDF105A
Device Lot NumberGA5041
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/21/2014
Was Device Evaluated by Manufacturer? No
Date Device Manufactured02/09/2014
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-